Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-08-08
2006-08-08
Shameem, Golam M. M. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S106000, C544S162000, C544S358000, C544S386000, C546S184000, C546S245000, C548S530000, C548S953000, C564S169000, C514S255060, C514S617000
Reexamination Certificate
active
07087604
ABSTRACT:
The present application describes modulators of MCP-1 of formula (I):or pharmaceutically acceptable salt forms thereof, useful for the prevention of rheumatoid arthritis, multiple sclerosis, atherosclerosis, asthma, restinosis, organ transplantation, and cancer.
REFERENCES:
patent: 4240957 (1980-12-01), Hirai et al.
patent: 6706712 (2004-03-01), Cherney
patent: 2003/0060459 (2003-03-01), Cherney et al.
patent: 2004/0110736 (2004-06-01), Cherney
patent: 2004/0186140 (2004-09-01), Cherney et al.
patent: 2004/0186143 (2004-09-01), Carter et al.
patent: 2004/0235835 (2004-11-01), Carter
patent: 2004/0235836 (2004-11-01), Cherney
patent: 2005/0043392 (2005-02-01), Carter
patent: 2005/0054626 (2005-03-01), Carter et al
patent: 2005/0054627 (2005-03-01), Carter et al.
patent: 2005/0065147 (2005-03-01), Carter et al.
patent: 4302051 (1993-01-01), None
patent: 4326344 (1993-08-01), None
patent: 0490450 (1991-12-01), None
patent: 0672656 (1995-03-01), None
patent: 0529737 (1997-10-01), None
patent: WO 93/09135 (1993-05-01), None
patent: WO 94/13695 (1994-06-01), None
patent: WO 94/20062 (1994-09-01), None
patent: WO 96/09297 (1996-03-01), None
patent: WO 96/09836 (1996-04-01), None
patent: WO 97/22618 (1997-06-01), None
patent: WO 98/08802 (1998-03-01), None
patent: WO 99/11657 (1999-03-01), None
patent: WO 99/11658 (1999-03-01), None
patent: WO 99/26615 (1999-06-01), None
patent: WO 99/47545 (1999-09-01), None
patent: WO 00/14097 (2000-03-01), None
patent: WO 00/39115 (2000-07-01), None
patent: WO 00/55126 (2000-09-01), None
patent: WO 00/59881 (2000-10-01), None
patent: WO 00/69820 (2000-11-01), None
patent: WO 00/69855 (2000-11-01), None
patent: WO 01/07436 (2001-02-01), None
patent: WO 01/19816 (2001-03-01), None
patent: WO 02/50019 (2002-06-01), None
patent: WO 0250019 (2002-06-01), None
patent: WO 02060859 (2002-08-01), None
patent: WO 02/060859 (2002-08-01), None
patent: WO 02/088106 (2002-11-01), None
patent: WO 03075853 (2003-09-01), None
patent: WO 2004071449 (2004-08-01), None
patent: WO 2004071460 (2004-08-01), None
patent: WO004098516 (2004-11-01), None
patent: WO 2004098512 (2004-11-01), None
patent: WO 2005020899 (2005-03-01), None
patent: WO 2005021498 (2005-03-01), None
patent: WO 2005021499 (2005-03-01), None
patent: WO 2005021500 (2005-03-01), None
Shameem Golam M. M.
Van Atten Mary
LandOfFree
Cyclic derivatives as modulators of chemokine receptor activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclic derivatives as modulators of chemokine receptor activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic derivatives as modulators of chemokine receptor activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3644656